LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Phillip B. Donenberg, its CFO, will present an overview of the company and its recently completed acquisition of Cell Genesys, as well as give a LibiGel® (testosterone gel) update at Merriman Curhan Ford’s 6th Annual Investor Summit today, Tuesday November 10, 2009 at the Hotel Sofitel in New York City. Mr. Donenberg will present at 12:40 pm local time.
